Elevation Oncology, Inc. (ELEV) Financials
Stock symbol ELEV is outdated, potentially delisted? Maybe it is available on other exchange?
ELEV Assets vs Liabilities
| Date | Assets | Liabilities |
|---|---|---|
| Dec. 31, 2023 | 89.1 million | 34.3 million |
| Sept. 30, 2023 | 100.0 million | 37.6 million |
| June 30, 2023 | 110.4 million | 38.2 million |
| March 31, 2023 | 76.9 million | 43.1 million |
ELEV Free Cash Flow and Stock based compensation
Graph available only for paid members. Upgrade to see it.
| Date | Free Cash Flow | Stock based compensation |
|---|---|---|
| Dec. 31, 2023 | -12.2 million | 284000 |
| Sept. 30, 2023 | -13.4 million | 843000 |
| June 30, 2023 | -13.8 million | 744000 |
| March 31, 2023 | -16.8 million | 1.5 million |
ELEV Net Income
No data available :(
ELEV Cash and Debt
Graph available only for paid members. Upgrade to see it.
| Date | Cash | Debt | Capital Lease |
|---|---|---|---|
| Dec. 31, 2023 | 83.1 million | - | - |
| Sept. 30, 2023 | 94.8 million | - | - |
| June 30, 2023 | 107.9 million | 29.8 million | - |
| March 31, 2023 | 73.9 million | 29.6 million | - |
ELEV Shares Outstanding
ELEV Expenses
Graph available only for paid members. Upgrade to see it.
| Date | Capex | R&D | G&A | S&M |
|---|---|---|---|---|
| Dec. 31, 2023 | - | 4.7 million | 3.3 million | 10000 |
| Sept. 30, 2023 | - | 7.4 million | 3.5 million | - |
| June 30, 2023 | - | 6.0 million | 3.8 million | - |
| March 31, 2023 | - | 7.3 million | 4.3 million | - |
ELEV Cost of Revenue
Graph available only for paid members. Upgrade to see it.
| Date | Revenue | Cost of Revenue |
|---|---|---|
| Dec. 31, 2023 | - | 10000 |
| Sept. 30, 2023 | - | 9000 |
| June 30, 2023 | - | 10000 |
| March 31, 2023 | - | 10000 |
ELEV
Price: $0.36
52 week price:
Earnings Per Share: -0.81 USD
P/E Ratio: -0.45
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 9000
Market Capitalization: 21.6 million